168 related articles for article (PubMed ID: 31188197)
1. Prospective Comparison of the Prognostic Relevance of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow of a Single Patient's Cohort With Esophageal Cancer.
Konczalla L; Ghadban T; Effenberger KE; Wöstemeier A; Riethdorf S; Uzunoglu FG; Izbicki JR; Pantel K; Bockhorn M; Reeh M
Ann Surg; 2021 Feb; 273(2):299-305. PubMed ID: 31188197
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity.
Gröbe A; Blessmann M; Hanken H; Friedrich RE; Schön G; Wikner J; Effenberger KE; Kluwe L; Heiland M; Pantel K; Riethdorf S
Clin Cancer Res; 2014 Jan; 20(2):425-33. PubMed ID: 24218516
[TBL] [Abstract][Full Text] [Related]
3. Hamburg-Glasgow classification: preoperative staging by combination of disseminated tumour load and systemic inflammation in oesophageal carcinoma.
Reeh M; Ghadban T; Uzunoglu FG; Nentwich MF; Bockhorn M; Pantel K; Izbicki JR; Vashist YK
Br J Cancer; 2017 Aug; 117(5):612-618. PubMed ID: 28704837
[TBL] [Abstract][Full Text] [Related]
4. Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer.
Reeh M; Effenberger KE; Koenig AM; Riethdorf S; Eichstädt D; Vettorazzi E; Uzunoglu FG; Vashist YK; Izbicki JR; Pantel K; Bockhorn M
Ann Surg; 2015 Jun; 261(6):1124-30. PubMed ID: 25607767
[TBL] [Abstract][Full Text] [Related]
5. Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival.
Mathiesen RR; Borgen E; Renolen A; Løkkevik E; Nesland JM; Anker G; Ostenstad B; Lundgren S; Risberg T; Mjaaland I; Kvalheim G; Lønning PE; Naume B
Breast Cancer Res; 2012 Aug; 14(4):R117. PubMed ID: 22889108
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous Detection of Disseminated and Circulating Tumor Cells in Primary Breast Cancer Patients.
Hartkopf AD; Wallwiener M; Hahn M; Fehm TN; Brucker SY; Taran FA
Cancer Res Treat; 2016 Jan; 48(1):115-24. PubMed ID: 25687853
[TBL] [Abstract][Full Text] [Related]
7. Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer.
Hartkopf AD; Stefanescu D; Wallwiener M; Hahn M; Becker S; Solomayer EF; Fehm TN; Brucker SY; Taran FA
Breast Cancer Res Treat; 2014 Sep; 147(2):345-51. PubMed ID: 25151295
[TBL] [Abstract][Full Text] [Related]
8. Disseminated tumor cells in bone marrow and the natural course of resected esophageal cancer.
Vashist YK; Effenberger KE; Vettorazzi E; Riethdorf S; Yekebas EF; Izbicki JR; Pantel K
Ann Surg; 2012 Jun; 255(6):1105-12. PubMed ID: 22580852
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and Predictive Value of Circulating and Disseminated Tumor Cells in Breast Cancer: A National Cancer Database (NCDB) Analysis.
Bilani N; Elson L; Liang H; Elimimian EB; Arteta-Bulos R; Nahleh Z
Technol Cancer Res Treat; 2020; 19():1533033820980107. PubMed ID: 33287661
[TBL] [Abstract][Full Text] [Related]
10. Absence of HER2 Expression of Circulating Tumor Cells in Patients with Non-Metastatic Esophageal Cancer.
Woestemeier A; Ghadban T; Riethdorf S; Harms-Effenberger K; Konczalla L; Uzunoglu FG; Izbicki JR; Pantel K; Bockhorn M; Reeh M
Anticancer Res; 2018 Oct; 38(10):5665-5669. PubMed ID: 30275185
[TBL] [Abstract][Full Text] [Related]
11. Correlation of circulating or disseminated tumor cells with the Oncotype DX Recurrence Score.
Singh P; Tevis SE; Hall CS; Meas S; Hwang RF; Lucci A
Breast Cancer Res Treat; 2020 Dec; 184(3):683-687. PubMed ID: 32888140
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a marker independent isolation method for circulating tumor cells in esophageal adenocarcinoma.
Philippron A; Depypere L; Oeyen S; De Laere B; Vandeputte C; Nafteux P; De Preter K; Pattyn P
PLoS One; 2021; 16(5):e0251052. PubMed ID: 33961658
[TBL] [Abstract][Full Text] [Related]
13. Different prognostic value of circulating and disseminated tumor cells in primary breast cancer: Influence of bisphosphonate intake?
Kasimir-Bauer S; Reiter K; Aktas B; Bittner AK; Weber S; Keller T; Kimmig R; Hoffmann O
Sci Rep; 2016 May; 6():26355. PubMed ID: 27212060
[TBL] [Abstract][Full Text] [Related]
14. Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells.
Fehm T; Hoffmann O; Aktas B; Becker S; Solomayer EF; Wallwiener D; Kimmig R; Kasimir-Bauer S
Breast Cancer Res; 2009; 11(4):R59. PubMed ID: 19664291
[TBL] [Abstract][Full Text] [Related]
15. Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow.
Deng G; Krishnakumar S; Powell AA; Zhang H; Mindrinos MN; Telli ML; Davis RW; Jeffrey SS
BMC Cancer; 2014 Jun; 14():456. PubMed ID: 24947048
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients.
Molloy TJ; Bosma AJ; Baumbusch LO; Synnestvedt M; Borgen E; Russnes HG; Schlichting E; van't Veer LJ; Naume B
Breast Cancer Res; 2011 Jun; 13(3):R61. PubMed ID: 21672237
[TBL] [Abstract][Full Text] [Related]
17. Detection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients - a prospective study.
Hinz S; Hendricks A; Wittig A; Schafmayer C; Tepel J; Kalthoff H; Becker T; Röder C
BMC Cancer; 2017 Jan; 17(1):53. PubMed ID: 28086834
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Glasgow Prognostic Score as additional independent prognostic parameter for patients with esophageal cancer after curative esophagectomy.
Lindenmann J; Fink-Neuboeck N; Avian A; Pichler M; Habitzruther M; Maier A; Smolle-Juettner FM
Eur J Surg Oncol; 2017 Feb; 43(2):445-453. PubMed ID: 27839896
[TBL] [Abstract][Full Text] [Related]
19. Presence of disseminated tumor cells in bone marrow correlates with tumor stage and nodal involvement in cervical cancer patients.
Fehm T; Banys M; Rack B; Jäger B; Hartkopf A; Taran FA; Janni W
Int J Cancer; 2014 Feb; 134(4):925-31. PubMed ID: 23921989
[TBL] [Abstract][Full Text] [Related]
20. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.
Krishnamurthy S; Cristofanilli M; Singh B; Reuben J; Gao H; Cohen EN; Andreopoulou E; Hall CS; Lodhi A; Jackson S; Lucci A
Cancer; 2010 Jul; 116(14):3330-7. PubMed ID: 20564098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
